Author Affiliations: Departments of Neurology (Drs Keegan and Pittock) and Laboratory Medicine and Pathology (Dr Pittock), Mayo Clinic, Rochester, Minnesota.
In recent years, combined clinical, radiological, pathological, and serological findings have resulted in the identification of novel and distinct inflammatory central nervous system (CNS) disorders. One such example is the disease entity of neuromyelitis optica (NMO) spectrum disorders. These relapsing autoimmune inflammatory CNS disorders are unified by detection of the serum biomarker NMO-IgG, which targets the astrocytic aquaporin-4 water channel.1 Before the identification of its specific serum biomarker, investigators had reported that NMO was clinically, radiologically, and pathologically distinct from multiple sclerosis (MS).1
Keegan BM, Pittock SJ. Cutting-edge Questions About CLIPPERS (Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids). Arch Neurol. 2012;69(7):819–820. doi:10.1001/archneurol.2012.1015
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.